Ascension Living Via Christi Village McLean: Drug Restraint Violations - KS
The citation against Ascension Living Via Christi Village McLean, issued following a complaint inspection completed August 14, is one of eight deficiencies federal health inspectors found at the facility during that visit. The psychotropic drug finding drew a scope and severity rating of D, meaning inspectors characterized it as isolated and found no actual harm to residents. But the rating also carries a formal acknowledgment that the potential for more than minimal harm existed.
That distinction matters. Psychotropic medications, a broad class that includes antipsychotics, antidepressants, anti-anxiety drugs, and sedatives, carry real risks for elderly nursing home residents. Antipsychotics in particular carry a black-box warning from the Food and Drug Administration noting an increased risk of death when used in older adults with dementia-related psychosis. Anti-anxiety drugs and sedatives can cause falls, confusion, and a kind of chemical fog that strips residents of the alertness and engagement that define a meaningful daily life. When those medications are given without adequate clinical justification, or in doses that exceed what a resident's condition requires, they function less as treatment than as a tool for managing behavior, keeping residents quiet and compliant in ways that benefit staff more than patients.
Federal inspectors have a specific name for that. They call it a chemical restraint.
The regulatory tag attached to the McLean citation, F0605, exists precisely because the history of nursing home care in the United States includes decades of overmedication. Surveys conducted by the federal government have repeatedly found that nursing homes administer antipsychotic drugs to residents who have no diagnosis that warrants them, sometimes because the resident is agitated, sometimes because they wander, sometimes because they call out repeatedly and staff find it disruptive. The drugs quiet the behavior. They also quiet the person.
At McLean, the inspection report does not describe which residents were affected, which medications were involved, or what clinical decisions preceded the prescriptions inspectors found problematic. The narrative provided to the public is narrow: a deficiency was cited, it was isolated, no actual harm was documented, and the facility reported a correction date of September 10, 2025, less than four weeks after the inspection closed.
What the record does not say is whether anyone reviewed the affected resident's medication regimen before the inspector arrived, whether a physician was contacted, or whether the drug in question was discontinued or adjusted. The correction date is a self-reported figure. The facility told regulators it had fixed the problem by September 10. Whether that means a resident's prescription was changed, a care plan was updated, or a staff member attended a training session is not reflected in the public record.
The psychotropic drug citation was not the only problem inspectors found. Seven additional deficiencies were cited during the same August 14 visit, though the inspection report provided here does not detail what those violations involved. Eight deficiencies in a single complaint inspection is a significant finding for any facility. Complaint inspections, unlike standard annual surveys, are typically triggered by a specific allegation, which means inspectors arrived at McLean already looking at something. What they found when they got there extended well beyond whatever prompted the original complaint.
Ascension Living Via Christi Village McLean is part of the Ascension Living network, a Catholic health ministry operating senior living communities across multiple states. The Via Christi name has been part of Wichita's health care landscape for generations, carrying with it a particular weight of community trust. Residents and families who choose a facility affiliated with a major Catholic health system often do so partly because of that trust, the assumption that a mission-driven organization will bring a different standard of attention and care to vulnerable people.
That assumption is not always wrong. But it is also not a substitute for compliance.
The federal government's nursing home oversight system is built around the idea that facilities must demonstrate, on an ongoing basis, that residents are free from unnecessary chemical sedation. The burden is not on families to prove a drug was inappropriate. The burden is on the facility to document that every psychotropic medication is clinically justified, regularly reviewed, and given at the lowest effective dose. When inspectors find that burden has not been met, they cite a deficiency. When the deficiency involves a medication that can restrain a person's ability to move through their day with awareness and agency, the regulatory framework treats it as a freedom violation, not merely a clinical one.
That framing is intentional. The nursing home reform law passed by Congress in 1987, which created the modern federal inspection system, was written in the aftermath of congressional hearings that documented widespread physical and chemical restraint of nursing home residents. Elderly people were being tied to chairs, sedated into passivity, and left to sit in corridors because it was easier than providing adequate staffing and individualized care. The law that emerged from those hearings declared that nursing home residents have the right to be free from restraints imposed for the convenience of staff. Chemical restraints were included in that prohibition from the beginning.
Nearly four decades later, inspectors are still citing nursing homes for the same category of violation. The drugs have changed, the documentation requirements have grown more elaborate, and the penalties have increased. The underlying dynamic, the temptation to manage a difficult or demanding resident with medication rather than engagement, has proven more durable than any regulatory intervention.
At McLean, the inspection found one isolated instance. No resident was documented as harmed. The facility says it corrected the problem within 27 days. By the metrics federal regulators use to score and publicize nursing home performance, this citation will register as a minor entry in a longer record.
But for the resident at the center of it, the question of whether a drug was restraining their ability to function is not a regulatory abstraction. It is the question of whether they could stay awake through a visit from a family member, whether they could follow a conversation, whether they could feel the texture of an ordinary afternoon rather than moving through it at a remove. Those are not small things to lose. They are, for someone living out their final years in a nursing home, often the only things left.
The facility has until September 10 to demonstrate to regulators that the violation has been addressed. Whether the resident whose care prompted the citation is still a resident at McLean, and whether their medication regimen looks different now than it did when inspectors walked through the door in August, is not something the public record answers.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Ascension Living Via Christi Village Mclean from 2025-08-14 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: October 20, 2026 · Our methodology
ASCENSION LIVING VIA CHRISTI VILLAGE MCLEAN in WICHITA, KS was cited for violations during a health inspection on August 14, 2025.
The psychotropic drug finding drew a scope and severity rating of D, meaning inspectors characterized it as isolated and found no actual harm to residents.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.